Taysha Corp (TSHA) Market Capitalization

Public company logo of tayshagtx.com (TSHA)

Taysha Gene Therapies (TSHA) operates with a strict focus on treating Rett syndrome, which creates high risks due to dependence on clinical trial results. Revenues rely on insurance fund reimbursements for expensive CNS pathology therapies, and the market capitalization stands at 1.30. The price action history confirms that optimizing the cold chain supply to clinics is critical for maintaining profitability and protecting the drugs.

tayshagtx.com - TSHA Market Capitalization (period 07/04/2022 - 11/18/2026)

Taysha Gene Therapies - analytical breakdowns and key metrics (TSHA)

- market price and analyst price targets:
Fundamental company analysis:Taysha Gene Therapies, Inc. (TSHA)
Original product of Taysha Corp

To minimize investment risks, it is necessary to filter out market noise and identify the true fundamental signal of an asset's value. The total value of all shares, which forms the current market capitalization of the issuer, measures market confidence in business transparency and potential, which for Taysha Gene Therapies (TSHA) directly depends on the success of TSHA-102 clinical trials and the scaling of Rett syndrome therapy.

Competing companies

Market Capitalization TEM (Tempus AI, Inc)|Market Capitalization Qiagen Group|IONS - Market Value|Market Value repligen.com|RNA: Market Capitalization|Market Valuation CRSP (CRISPR Therapeutics)|Market Value GeneDx Holdings Corp.|Market Capitalization RARE (Ultragenyx Corp)|Market Value Beam Therapeutics (BEAM)|Sarepta Therapeutics, Inc. - Market Capitalization|Market Capitalization TWST (twistbioscience.com)|Market Value TXG (10x Genomics Corp)|Intellia Corp - Market Capitalization|Market Capitalization Stoke Therapeutics STOK|BLFS: Market Capitalization|WVE (Wave Life Sciences) - Market Value|Market Valuation MAZE|Market Value Sionna Therapeutics, Inc. SION|Market Value Prime Medicine Bio (PRME)|uniQure N.V. (QURE) - Market Capitalization|Market Capitalization MGTX (MeiraGTx Corp)|RGNX: Market Capitalization|SLDB: Market Valuation|OCGN (Ocugen Corp) - Market Capitalization|PACB: Market Capitalization|Market Valuation Benitec Biopharma Inc.|Market Valuation DSGN|Rocket Pharmaceuticals - Market Valuation|Market Capitalization FDMT|LXEO - Market Value|Korro Bio, Inc. - Market Valuation|EDIT: Market Capitalization|SLN - Market Value|PRQR - Market Capitalization|CDXS (Codexis, Inc.) - Market Valuation|Sangamo Therapeutics, Inc. - Market Value|Market Valuation NAUT|Market Valuation Metagenomi, Inc. (MGX)|Market Value precisionbiosciences.com (DTIL)|GBIO - Market Value|Market Capitalization BOLD (Boundless Bio Inc.)|Market Capitalization Exicure, Inc. XCUR|Imunon Inc - Market Capitalization|Market Capitalization phiopharma.com PHIO|Mustang Bio Corp (MBIO) - Market Value|Market Value TransCode Therapeutics (RNAZ)|BNGO (Bionano Genomics) - Market Capitalization|Market Valuation Applied DNA Sciences, Inc. (APDN)|Market Value Bluebird Bio (BLUE)|IPA - Market Value|Market Value omegatherapeutics.com OMGA|singulargenomics.com (OMIC) - Market Value|RGLS - Market Value|Market Capitalization Syros Pharmaceuticals Inc. SYRS|Telesis Bio, Inc. (TBIO) - Market Value|TCON - Market Capitalization|Market Value Unity Biotechnology, Inc.